Khosla Ventures Acquisition (KVSA): Price and Financial Metrics


Khosla Ventures Acquisition (KVSA): $9.76

0.02 (+0.21%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

KVSA Stock Price Chart Interactive Chart >

Price chart for KVSA

KVSA Price/Volume Stats

Current price $9.76 52-week high $10.27
Prev. close $9.74 52-week low $9.58
Day low $9.75 Volume 39,845
Day high $9.76 Avg. volume 81,329
50-day MA $9.77 Dividend yield N/A
200-day MA $9.81 Market Cap 346.38M

Khosla Ventures Acquisition (KVSA) Company Bio


Khosla Ventures Acquisition is a newly incorporated blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities.


KVSA Latest News Stream


Event/Time News Detail
Loading, please wait...

KVSA Latest Social Stream


Loading social stream, please wait...

View Full KVSA Social Stream

Latest KVSA News From Around the Web

Below are the latest news stories about Khosla Ventures Acquisition Co that investors may wish to consider to help them evaluate KVSA as an investment opportunity.

Vinod Khosla said market swings don't matter much in venture

The billionaire investor says he invests for the longterm and doesn't pay much attention to the ups and downs of the market.

Yahoo | January 31, 2022

Westchester Capital Funds Buys Far Peak Acquisition Corp, Far Peak Acquisition Corp, Reinvent ...

Investment company Westchester Capital Funds (Current Portfolio) buys Far Peak Acquisition Corp, Far Peak Acquisition Corp, Reinvent Technology Partners Y, Kensington Capital Acquisition Corp V, Isos Acquisition Corp, sells , Far Peak Acquisition Corp, Far Peak Acquisition Corp, Reinvent Technology Partners Y, Reinvent Technology Partners Y during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Westchester Capital Funds.

Yahoo | December 28, 2021

Khosla Ventures SPAC cancels $2.8B Valo Health merger a day before shareholder vote

Khosla and Boston-based Valo Health gave “current market conditions, particularly in the biotechnology area,” as the reason for calling off the deal, which was announced in June.

Yahoo | November 16, 2021

Valo Health and Khosla Ventures Acquisition Co. Mutually Agree to Terminate Business Combination Agreement

Valo Health, LLC ("Valo"), the technology company using human-centric data and artificial intelligence (AI) powered computation to transform the drug discovery and development process and Khosla Ventures Acquisition Co. (Nasdaq: KVSA) ("KVSA"), a special purpose acquisition company sponsored by affiliates of Khosla Ventures, LLC, announced today that both companies have mutually agreed to terminate their previously announced agreement and plan of merger (the "Business Combination Agreement"), ef

Yahoo | November 15, 2021

Valo Health and Khosla Ventures Acquisition Co. Announce Additional PIPE Commitments

Valo Health, LLC ("Valo"), the technology company using human-centric data and artificial intelligence (AI) powered computation to transform the drug discovery and development process, and Khosla Ventures Acquisition Co. (Nasdaq: KVSA) ("KVSA"), a special purpose acquisition company sponsored by an affiliate of Khosla Ventures, LLC ("Khosla Ventures"), today announced that the private placement of common stock ("PIPE") investment in connection with their previously announced business combination

Yahoo | November 9, 2021

Read More 'KVSA' Stories Here

KVSA Price Returns

1-mo -0.46%
3-mo 0.21%
6-mo -0.91%
1-year -2.50%
3-year N/A
5-year N/A
YTD 0.62%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.3702 seconds.